Sökning: WFRF:(Toppari Jorma) >
Islet Autoimmunity ...
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
-
- Anand, Vibha (författare)
- IBM Thomas J. Watson Research Center
-
- Li, Ying (författare)
- IBM Thomas J. Watson Research Center
-
- Liu, Bin (författare)
- IBM Thomas J. Watson Research Center
-
visa fler...
-
- Ghalwash, Mohamed (författare)
- Ain Shams University,IBM Thomas J. Watson Research Center
-
- Koski, Eileen (författare)
- IBM Thomas J. Watson Research Center
-
- Ng, Kenney (författare)
- IBM Thomas J. Watson Research Center
-
- Dunne, Jessica L (författare)
- Juvenile Diabetes Research Foundation
-
- Jönsson, Josefine (författare)
- Lund University,Lunds universitet,Diabetes - epigenetik,Forskargrupper vid Lunds universitet,Diabetes - Epigenetics,Lund University Research Groups,Skåne University Hospital
-
- Winkler, Christiane (författare)
- Helmholtz Zentrum München,Technical University of Munich
-
- Knip, Mikael (författare)
- Helsinki University Central Hospital,University of Helsinki,Folkhälsan Research Center,Tampere University Hospital
-
- Toppari, Jorma (författare)
- Turku University Hospital,University of Turku
-
- Ilonen, Jorma (författare)
- Turku University Hospital,University of Turku
-
- Killian, Michael B (författare)
- Pacific Northwest Research Institute
-
- Frohnert, Brigitte I (författare)
- University of Colorado
-
- Lundgren, Markus (författare)
- Helmholtz Zentrum München
-
- Ziegler, Anette-Gabriele (författare)
- Technical University of Munich,Helmholtz Zentrum München
-
- Hagopian, William (författare)
- Pacific Northwest Research Institute
-
- Veijola, Riitta (författare)
- Oulu University Hospital,University of Oulu
-
- Rewers, Marian (författare)
- University of Colorado
-
visa färre...
-
IBM Thomas J Watson Research Center Ain Shams University (creator_code:org_t)
-
- 2021-06-23
- 2021
- Engelska 8 s.
-
Ingår i: Diabetes Care. - : American Diabetes Association. - 1935-5548 .- 0149-5992. ; 44, s. 2269-2276
- Relaterad länk:
-
http://dx.doi.org/10...
-
visa fler...
-
https://push-zb.helm...
-
https://lup.lub.lu.s...
-
https://doi.org/10.2...
-
visa färre...
Abstract
Ämnesord
Stäng
- OBJECTIVE: To combine prospective cohort studies, by including HLA harmonization, and estimate risk of islet autoimmunity and progression to clinical diabetes.RESEARCH DESIGN AND METHODS: For prospective cohorts in Finland, Germany, Sweden, and the U.S., 24,662 children at increased genetic risk for development of islet autoantibodies and type 1 diabetes have been followed. Following harmonization, the outcomes were analyzed in 16,709 infants-toddlers enrolled by age 2.5 years.RESULTS: In the infant-toddler cohort, 1,413 (8.5%) developed at least one autoantibody confirmed at two or more consecutive visits (seroconversion), 865 (5%) developed multiple autoantibodies, and 655 (4%) progressed to diabetes. The 15-year cumulative incidence of diabetes varied in children with one, two, or three autoantibodies at seroconversion: 45% (95% CI 40-52), 85% (78-90), and 92% (85-97), respectively. Among those with a single autoantibody, status 2 years after seroconversion predicted diabetes risk: 12% (10-25) if reverting to autoantibody negative, 30% (20-40) if retaining a single autoantibody, and 82% (80-95) if developing multiple autoantibodies. HLA-DR-DQ affected the risk of confirmed seroconversion and progression to diabetes in children with stable single-autoantibody status. Their 15-year diabetes incidence for higher- versus lower-risk genotypes was 40% (28-50) vs. 12% (5-38). The rate of progression to diabetes was inversely related to age at development of multiple autoantibodies, ranging from 20% per year to 6% per year in children developing multipositivity in ≤2 years or >7.4 years, respectively.CONCLUSIONS: The number of islet autoantibodies at seroconversion reliably predicts 15-year type 1 diabetes risk. In children retaining a single autoantibody, HLA-DR-DQ genotypes can further refine risk of progression.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Publikations- och innehållstyp
- art (ämneskategori)
- ref (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Anand, Vibha
-
Li, Ying
-
Liu, Bin
-
Ghalwash, Mohame ...
-
Koski, Eileen
-
Ng, Kenney
-
visa fler...
-
Dunne, Jessica L
-
Jönsson, Josefin ...
-
Winkler, Christi ...
-
Knip, Mikael
-
Toppari, Jorma
-
Ilonen, Jorma
-
Killian, Michael ...
-
Frohnert, Brigit ...
-
Lundgren, Markus
-
Ziegler, Anette- ...
-
Hagopian, Willia ...
-
Veijola, Riitta
-
Rewers, Marian
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Endokrinologi oc ...
- Artiklar i publikationen
-
Diabetes Care
- Av lärosätet
-
Lunds universitet